Acutaas Chemical

Why is Acutaas Chemicals Ltd falling/rising?

As of 19-Jun, Acutaas Chemicals Ltd's stock price has risen to 3,243.95, reflecting a 3.44% increase due to strong financial performance and positive market sentiment. The company has shown impressive year-to-date returns of 90.47% and consistent growth in net sales and operating profit.

As of 19-Jun, Acutaas Chemicals Ltd is experiencing a rise in its stock price, currently at 3,243.95, reflecting an increase of 107.95 or 3.44%. This upward movement can be attributed to several positive factors. The stock has outperformed the sector by 2.57% today and has shown consistent gains over the last two days, accumulating a total return of 8.32% during this period. Additionally, the stock reached an intraday high of Rs 3,262.3, marking a 4.03% increase.<BR><BR>In terms of longer-term performance, Acutaas Chemicals Ltd has demonstrated impressive returns, with a year-to-date increase of 90.47% and a staggering 198.18% rise over the past year. The company has also shown strong fundamentals, with net sales growing at an annual rate of 26.68% and operating profit increasing by 47.03%. Furthermore, the company has reported positive results for the last seven consecutive quarters, indicating robust financial health.<BR><BR>The stock is trading above its moving averages across various time frames, which is typically a bullish signal. High institutional holdings at 39.1% suggest confidence from larger investors, who have increased their stake by 0.72% over the previous quarter. This institutional interest often reflects a strong belief in the company's potential for growth.<BR><BR>Despite a slight decline in investor participation, with delivery volume decreasing by 5.24% against the 5-day average, the overall market performance and the company's strong financial metrics contribute to the stock's rising price. Thus, the combination of solid financial performance, positive market sentiment, and institutional support are key factors driving the rise in Acutaas Chemicals Ltd's stock price.

Which are the latest news on Acutaas Chemical?

What does Acutaas Chemical do?

Acutaas Chemicals Ltd is a Small Cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of 433 Cr and a net profit of 132 Cr for March 2026. It was originally established as "Ami Organics" in 2004 and later incorporated as a Private Limited Company in 2007.

Overview: <BR>Acutaas Chemicals Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Small Cap company.<BR><BR>History: <BR>The company was initially formed as a partnership firm named "Ami Organics" on 03 January 2004 in Surat, India. It transitioned to a Private Limited Company under the name "Ami Organics Private Limited" with a Certificate of Incorporation dated 12 June 2007. The latest quarterly results report net sales and profit for March 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 433 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 132 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 26,860 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 74.00 <BR>Industry P/E: 42 <BR>Dividend Yield: 0.05% <BR>Debt-Equity: -0.11 <BR>Return on Equity: 21.54% <BR>Price to Book: 15.84 <BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

How big is Acutaas Chemical?

As of 10th June, Acutaas Chemicals Ltd has a market capitalization of 26,860.00 Cr, with recent net sales of 1,339.37 Cr and net profit of 356.25 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Acutaas Chemicals Ltd has a market capitalization of 26,860.00 Cr, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 1,339.37 Cr, while the sum of Net Profit for the same period is 356.25 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2025. Shareholder's Funds are valued at 1,309.63 Cr, and Total Assets amount to 1,549.26 Cr.

Who are in the management team of Acutaas Chemical?

The management team of Acutaas Chemical includes Chairman Nareshbhai Ramjibhai Patel, Whole-time Directors Chetankumar Chhaganlal Vaghasia, Virendra Nath Mishra, and Ram Mohan Rao Locande, along with Independent Non-Executive Directors Girikrishna Maniar, Hetal Gandhi, Richa M. Goyal, and Anita Bandyopadhyay. They oversee the company's strategic direction and management.

The management team of Acutaas Chemical includes the following key members:<BR><BR>1. **Nareshbhai Ramjibhai Patel** - Chairman / Executive Director<BR>2. **Chetankumar Chhaganlal Vaghasia** - Whole-time Director<BR>3. **Virendra Nath Mishra** - Whole-time Director<BR>4. **Ram Mohan Rao Locande** - Whole-time Director<BR>5. **Girikrishna Maniar** - Independent Non-Executive Director<BR>6. **Hetal Gandhi** - Independent Non-Executive Director<BR>7. **Richa M. Goyal** - Independent Non-Executive Director<BR>8. **Anita Bandyopadhyay** - Independent Non-Executive Director<BR><BR>This team is responsible for the strategic direction and management of the company.

Who are the peers of the Acutaas Chemical?

Acutaas Chemical's peers include Ajanta Pharma, Glaxosmi Pharma, J B Chemicals, Emcure Pharma, Wockhardt, Sai Life, Piramal Pharma, Neuland Labs, Astrazeneca Pharma, and Pfizer. Acutaas Chemical leads in growth and returns, with a 1-year return of 186.73%, while Glaxosmi Pharma has the lowest return at -36.01%.

Peers: The peers of Acutaas Chemical are Ajanta Pharma, Glaxosmi. Pharma, J B Chemicals &, Emcure Pharma, Wockhardt, Sai Life, Piramal Pharma, Neuland Labs., Astrazeneca Phar, and Pfizer.<BR><BR>Quality Snapshot: Excellent management risk is observed at Ajanta Pharma, Glaxosmi. Pharma, and Astrazeneca Phar, while Good management risk is found at J B Chemicals &, Emcure Pharma, Neuland Labs., and Acutaas Chemical. Average management risk is present at Wockhardt and Sai Life, and the rest have a Below Average management risk. Growth is Excellent at Acutaas Chemical, Sai Life, and Emcure Pharma, while Below Average growth is noted at Ajanta Pharma, Glaxosmi. Pharma, and Astrazeneca Phar. Good growth is observed at J B Chemicals & and Piramal Pharma, with the rest showing Below Average growth. Capital Structure is Excellent at Ajanta Pharma, Glaxosmi. Pharma, Acutaas Chemical, and Neuland Labs., while Good capital structure is found at Emcure Pharma. Average capital structure is present at Wockhardt, and Below Average at Piramal Pharma.<BR><BR>Return Snapshot: Acutaas Chemical has the highest 1-year return at 186.73%, while Glaxosmi. Pharma has the lowest at -36.01%. Acutaas Chemical's return significantly outperforms all peers. Additionally, the six-month return is negative for Glaxosmi. Pharma, Piramal Pharma, and Astrazeneca Phar.

Are Acutaas Chemicals Ltd latest results good or bad?

Acutaas Chemicals Ltd's latest results are strong, with a 40.28% year-on-year increase in net sales and a 110.88% rise in net profit, alongside a record operating margin of 42.41%. The company has also delivered a 128.57% return to shareholders over the past year, significantly outperforming its sector.

Acutaas Chemicals Ltd's latest results are quite impressive and indicate strong performance. The company reported net sales of ₹432.75 crores for the quarter ending March 2026, marking a significant 40.28% increase compared to the same quarter last year. This growth is complemented by a robust sequential increase of 10.06% from the previous quarter.<BR><BR>Moreover, the operating margin expanded to a record high of 42.41%, reflecting exceptional operational efficiency and pricing power. The net profit for the quarter reached ₹131.76 crores, which is a remarkable 110.88% increase year-on-year.<BR><BR>In terms of shareholder returns, Acutaas Chemicals has outperformed its sector significantly, delivering a 128.57% return over the past year, compared to the modest 9.79% returns in the pharmaceuticals and biotechnology sector.<BR><BR>Overall, the results demonstrate strong operational momentum, improved profitability, and a solid financial position, making them favorable for the company.

Should I buy, sell or hold Acutaas Chemicals Ltd?

When is the next results date for Acutaas Chemicals Ltd?

The next results date for Acutaas Chemicals Ltd is 28 January 2026.

The next results date for Acutaas Chemicals Ltd is scheduled for 28 January 2026.

How has been the historical performance of Acutaas Chemical?

Acutaas Chemical has shown significant growth over the past five years, with net sales increasing from 340.61 Cr in March 2021 to 1,006.88 Cr in March 2025, and profit after tax rising from 54.00 Cr to 160.42 Cr in the same period. The company's total assets also expanded from 231.89 Cr to 1,549.26 Cr, reflecting strong operational efficiency and profitability.

Answer:<BR>The historical performance of Acutaas Chemical shows significant growth in net sales and profitability over the past five years, culminating in the fiscal year ending March 2025.<BR><BR>Breakdown:<BR>Acutaas Chemical's net sales have increased from 340.61 Cr in March 2021 to 1,006.88 Cr in March 2025, reflecting a strong upward trend. The total operating income has similarly risen, reaching 1,006.88 Cr in March 2025, up from 340.61 Cr in March 2021. The company's operating profit (PBDIT) has also shown substantial growth, climbing from 81.54 Cr in March 2021 to 249.01 Cr in March 2025, indicating improved operational efficiency. Profit before tax surged to 216.16 Cr in March 2025 from 71.73 Cr in March 2021, while profit after tax reached 160.42 Cr, up from 54.00 Cr in March 2021. The consolidated net profit for March 2025 stood at 158.71 Cr, a significant increase from 42.77 Cr in March 2024. Furthermore, total assets have expanded from 231.89 Cr in March 2020 to 1,549.26 Cr in March 2025, with total liabilities increasing from 231.89 Cr to 1,549.26 Cr in the same period. The cash flow from operating activities has remained positive, amounting to 118.00 Cr in March 2025, although cash flow from investing activities has been negative at -223.00 Cr. Overall, Acutaas Chemical has demonstrated robust growth in revenue and profitability, alongside a significant increase in total assets and liabilities.

Is Acutaas Chemical technically bullish or bearish?

As of October 1, 2025, the technical trend has shifted to bullish with strong indicators like the weekly MACD and Bollinger Bands supporting upward momentum, although caution is advised due to a mildly bearish monthly MACD and Dow Theory on the weekly timeframe.

As of 1 October 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish, indicating upward momentum. Daily moving averages are also bullish, reinforcing the positive trend. However, the monthly MACD is mildly bearish and the Dow Theory shows a mildly bearish stance on the weekly timeframe, which suggests some caution. Overall, the strength of the bullish trend is supported by the KST being bullish on both weekly and monthly timeframes.

Who are the top shareholders of the Acutaas Chemical?

The top shareholders of Acutaas Chemical include promoters, with Nareshkumar Ramjibhai Patel holding 19.34%, institutional investors with 19 mutual funds owning 13.02% and 110 foreign institutional investors holding 16.48%, and individual investors collectively owning 24.19%. The SBI Large & Midcap Fund is the largest public shareholder at 4.23%.

The top shareholders of Acutaas Chemical include a mix of promoters, institutional investors, and individual shareholders. The majority of the shares are held by promoters, with Nareshkumar Ramjibhai Patel being the promoter with the highest holding at 19.34%. <BR><BR>In terms of institutional investment, 19 mutual funds collectively hold 13.02% of the shares, while 110 foreign institutional investors (FIIs) hold 16.48%. The highest public shareholder is the SBI Large & Midcap Fund, which holds 4.23%. Additionally, individual investors collectively own 24.19% of the company.

Is Acutaas Chemical overvalued or undervalued?

As of September 17, 2021, Acutaas Chemical is considered very expensive and overvalued with a PE ratio of 58.75, significantly higher than its peers, despite strong returns of 84.28% over the past year, which outperformed the Sensex's 7.55% return.

As of 17 September 2021, Acutaas Chemical's valuation grade has moved from does not qualify to very expensive, indicating a significant shift in its market perception. The company is currently assessed as overvalued. Key financial ratios include a PE ratio of 58.75, an EV to EBITDA ratio of 39.16, and a PEG ratio of 0.64, which suggest that despite a high growth potential, the current price does not justify the earnings.<BR><BR>In comparison to its peers, Acutaas Chemical's PE ratio is notably higher than Godrej Industries Ltd., which has a PE of 46.63, and Deepak Nitrite Ltd., with a PE of 37.97. This reinforces the notion that Acutaas is trading at a premium relative to companies within the same sector. Additionally, while Acutaas has shown strong returns over the past year at 84.28%, it has underperformed against the Sensex's return of 7.55% during the same period, further highlighting its overvaluation in the current market context.

Has Acutaas Chemical declared dividend?

Acutaas Chemicals Ltd has declared a 30% dividend, amounting to 3 per share, with an ex-date of September 18, 2023. Despite this, the dividend yield is 0%, as the company has not provided significant dividend returns in recent years, although it has shown strong price performance.

Acutaas Chemicals Ltd has declared a 30% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 30%<BR>- Amount per share: 3 per share<BR>- Ex-date: 18 Sep 23<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the last 6 months, Acutaas Chemicals Ltd achieved a price return of 3.82%, with no dividend return, resulting in a total return of 3.82%.<BR><BR>Over the past year, the company saw a price return of 89.48%, with no dividend return, leading to a total return of 89.48%.<BR><BR>In the 2-year period, the price return was 91.7%, with a dividend return of 0.46%, culminating in a total return of 92.16%.<BR><BR>For the 3-year period, the price return reached 146.75%, with a dividend return of 1.41%, resulting in a total return of 148.16%.<BR><BR>In the last 4 years, there was no price or dividend return, resulting in a total return of 0.0%.<BR><BR>Over the 5-year period, the company also recorded no price or dividend return, leading to a total return of 0.0%.<BR><BR>Overall, Acutaas Chemicals Ltd has declared a dividend, but the dividend yield remains at 0%. The total returns over various periods indicate strong price performance, particularly in the 1 and 3-year periods, despite the lack of significant dividend contributions.